Title:
プロスタグランジンと一酸化窒素供与体との組み合わせ
Document Type and Number:
Japanese Patent JP6820847
Kind Code:
B2
Abstract:
The present invention relates to compositions for treating glaucoma and elevated ocular pressure. The compositions comprise a nitric oxide releasing isomannide derivative and a prostaglandin F2α analog.
Inventors:
Almirante, Nicoletta
Stroni, Laura
Bastia, Elena
Impagnattiello, Francesco
Stroni, Laura
Bastia, Elena
Impagnattiello, Francesco
Application Number:
JP2017526551A
Publication Date:
January 27, 2021
Filing Date:
November 17, 2015
Export Citation:
Assignee:
Nicox S.A.
International Classes:
A61K31/34; A61K31/5575; A61P27/02; A61P27/06; A61P43/00
Domestic Patent References:
| JP2009137971A | ||||
| JP2011511022A |
Foreign References:
| WO2014063923A1 |
Other References:
Rosenthal, R. et al.,Endothelin antagonism as an active principle for glaucoma therapy,British Journal of Pharmacology,2011年,Vol. 162, No.4,pp.806-816.
IMPAGNATIELLO F,A DUAL ACTING COMPOUND WITH LATANOPROST AMIDE AND NITRIC OXIDE RELEASING PROPERTIES, SHOWS OCULAR HYPOTENSIVE EFFECTS IN RABBITS AND DOGS,EXPERIMENTAL EYE RESEARCH,2011年 2月,VOL:93, NR:3,PAGE(S):243 - 249,URL,http://dx.doi.org/10.1016/j.exer.2011.02.006
IMPAGNATIELLO F,A DUAL ACTING COMPOUND WITH LATANOPROST AMIDE AND NITRIC OXIDE RELEASING PROPERTIES, SHOWS OCULAR HYPOTENSIVE EFFECTS IN RABBITS AND DOGS,EXPERIMENTAL EYE RESEARCH,2011年 2月,VOL:93, NR:3,PAGE(S):243 - 249,URL,http://dx.doi.org/10.1016/j.exer.2011.02.006
Attorney, Agent or Firm:
Patent business corporation Tsukuni